CKS1B overexpression has been documented in several cancers, including hepatocellular carcinoma (Lee et al., 2011), colon cancer (Wang et al., 2010), lung cancer (Zolota et al., 2010), oral squamous cell carcinoma (Kitajima et al., 2004), breast cancer (Slotky et al., 2005), and retinoblastoma (Zeng et al., 2019). Here, CKS1B is linked to cancer.